SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 157 filers reported holding SERES THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,228,589 | -39.8% | 936,382 | +21.1% | 0.01% | -38.1% |
| Q2 2023 | $3,704,524 | +173.0% | 773,387 | +223.2% | 0.02% | +133.3% |
| Q1 2023 | $1,356,757 | -23.7% | 239,287 | -24.6% | 0.01% | -40.0% |
| Q4 2022 | $1,778,062 | +35.4% | 317,511 | +55.2% | 0.02% | +7.1% |
| Q3 2022 | $1,313,000 | -37.8% | 204,592 | -31.0% | 0.01% | +7.7% |
| Q1 2022 | $2,111,000 | -23.2% | 296,435 | -10.2% | 0.01% | -7.1% |
| Q4 2021 | $2,749,000 | -20.5% | 329,981 | -33.6% | 0.01% | -41.7% |
| Q3 2021 | $3,459,000 | +14.2% | 496,964 | +291.3% | 0.02% | +26.3% |
| Q2 2021 | $3,029,000 | -5.6% | 126,997 | -18.6% | 0.02% | -13.6% |
| Q1 2021 | $3,210,000 | +242.2% | 155,921 | +307.1% | 0.02% | +144.4% |
| Q4 2020 | $938,000 | – | 38,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |